quantisnow
FeedTopReportsPricing
⌘K
Live feed
06:03:27·532d
SECFiling
Telesis Bio Inc. logo

SEC Form 10-Q filed by Telesis Bio Inc.

TBIO· Telesis Bio Inc.
Industrials
Full content unavailable. See the original source below.
Original source

Companies

  • TBIO
    Telesis Bio Inc.
    Industrials

Recent analyst ratings

  • Aug 4UpdateRoth Capital$38.00
  • Aug 3UpdateSVB Leerink$38.00
  • Aug 3UpdateWilliam Blair-
  • Jul 26UpdateRoth Capital$45.00

Related

  • PR330d
    Telesis Bio Announces Licensing Agreement with Regeneron to Adopt Gibson SOLA™ Platform for Rapid On-Site DNA and Gene Synthesis
  • PR401d
    Telesis Bio Secures up to $21 Million to Accelerate Adoption of Groundbreaking Gibson SOLA Technology for Rapid DNA and mRNA Synthesis
  • SEC464d
    SEC Form 15-12G filed by Telesis Bio Inc.
  • SEC472d
    SEC Form EFFECT filed by Telesis Bio Inc.
  • SEC472d
    SEC Form EFFECT filed by Telesis Bio Inc.
  • SEC475d
    SEC Form POS AM filed by Telesis Bio Inc.
  • SEC475d
    SEC Form POS AM filed by Telesis Bio Inc.
  • SEC475d
    SEC Form S-8 POS filed by Telesis Bio Inc.
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022